サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541001

腸疾患検査市場レポート：製品タイプ、手法、疾患タイプ、エンドユーザー、地域別、2024～2032年

Enteric Disease Testing Market Report by Product Type, Technique, Disease Type, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 143 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.20円
腸疾患検査市場レポート：製品タイプ、手法、疾患タイプ、エンドユーザー、地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の腸疾患検査市場規模は2023年に42億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに55億米ドルに達し、2024～2032年の間に3.1％の成長率（CAGR）を示すと予測しています。胃腸感染症の増加、早期発見に対する意識の高まり、診断技術の進歩、迅速かつ正確な検査法に対する需要の高まり、食品と水の安全基準に対する世界の関心の高まりなどが、市場の成長を後押しする要因の一部です。

腸疾患検査市場分析：

主要市場促進要因世界の胃腸感染症の流行増加は、市場の主要促進要因です。劣悪な衛生環境、汚染された水、食品由来病原体などの要因が、腸疾患の発生率上昇に寄与しています。迅速かつ正確な結果を提供する診断技術の著しい進歩が、市場の成長をさらに後押ししています。

主要市場動向：分子診断の普及が市場の主要動向です。ポリメラーゼ連鎖反応（PCR）や次世代シーケンシング（NGS）を含む技術は、その高い感度、特異性、迅速な納期により人気を集めています。これらの高度な診断法は、幅広い病原体の検出を可能にし、より正確で包括的な検査に貢献しています。

地理的動向：アジア太平洋が腸疾患検査市場の成長において最大の地域を占めています。衛生環境の悪化、医療意識の高まり、疾病管理に対する政府の取り組み、診断技術の進歩などにより、消化器感染症の発生率が高いことが、同地域全体の市場成長を牽引しています。

競合情勢：腸疾患検査業界の主要市場参入企業には、Abbott Laboratories、BD（Becton, Dickinson and Company）、Bio-Rad Laboratories Inc.、Biomerica Inc.、Biomerieux SA、Cepheid Inc.（Danaher Corporation）、Coris BioConcept、DiaSorin、Meridian Bioscience Inc.、Quest Diagnosticsなどがあります。

課題と機会：同市場は、遠隔地や低所得地域では高度な診断施設へのアクセスが限られており、タイムリーな疾患発見を妨げているなど、様々な課題に直面しています。しかし、迅速かつ正確な結果を提供する分子診断やポイントオブケア検査の進歩など、市場にはいくつかの機会もあります。

腸疾患検査市場傾向：

消化器感染症の発生率の上昇

特に発展途上地域において、劣悪な衛生環境、汚染された食品や水、高い人口密度による腸疾患の蔓延が拡大しており、効果的な診断検査に対する需要を牽引しています。Times of India紙が2024年に発表した記事によると、ベンガルールでは汚染された水源と劣悪な衛生環境に起因する消化器感染症が増加しています。幼児たちは下痢による脱水の危険にさらされており、ORSの重要性が強調されています。WHOによると、世界では下痢だけで約150万人が死亡しています。特に発展途上国に住む5歳以下の子どもたちは、下痢や嘔吐などの症状によって栄養失調になり、死に至る。このことが、腸疾患検査市場の価値をさらに大きく押し上げています。

高まる政府の取り組みと規制

台頭する政府と保健機関は、厳格な食品と水の安全基準を実施し、公衆衛生インフラに投資しています。これにより、アウトブレイクを防止し、公衆の安全を確保するための定期的で信頼性の高い腸疾患検査の必要性がさらに高まり、市場の成長にさらに寄与しています。例えば、2024年4月、インド食品安全基準局（FSSAI）は、デリー食品安全局と協力して、首都の主要市場を対象とした広範な啓発・感化プログラムを開始しました。同様に、モディ政権下の主要プログラムである国民健康ミッション（NHM）は、医療インフラの改善、必須医薬品と診断薬の提供、草の根レベルでの人材能力強化に重点を置いています。これらのイニシアチブは、患者が地元以外で高額な治療を受ける必要性を減らすことを目的としており、今後数年間の腸疾患検査市場予測をさらに後押しするものです。

診断技術の著しい進歩

ポリメラーゼ連鎖反応（PCR）や次世代シーケンシング（NGS）を含む分子診断における技術革新の増加は、腸内病原体の迅速、正確かつ包括的な検出を提供し、市場の成長を後押ししています。例えば、2023年8月、ArcticZymes Technologies（AZT）は新製品AZtaq（TM）DNA Polymeraseの発売を発表しました。AZtaq（TM）は、ポリメラーゼ連鎖反応（PCR）用途に適した高品質の耐熱性DNAポリメラーゼです。AZtaq（TM）の発売は、当社の分子ツール・ポートフォリオの自然な拡大です。PCRに不可欠な酵素である耐熱性DNAポリメラーゼは、分子診断や研究において極めて重要な役割を果たし、多くの応用を可能にします。これは、世界中で腸疾患検査市場の収益をさらに押し上げています。

腸疾患検査市場のセグメンテーション：

IMARC Groupは、市場の各セグメントにおける主要動向の分析と、2024～2032年までの世界、地域、国レベルでの予測を提供しています。製品タイプ、手技、疾患タイプ、エンドユーザー別に市場を分類しています。

製品タイプ別内訳

当レポートでは、製品タイプ別に市場を詳細に区分・分析しています。これには試薬と消耗品、機器が含まれます。

同市場における試薬と消耗品の需要は、正確で効率的な診断プロセスの必要性によって牽引されています。消化器系病原体の頻繁な検査には、高品質の試薬と消耗品を常に供給する必要があります。加えて、感染症流行率の上昇と分子検査法と迅速検査法の進歩が相まって、特殊な消耗品の使用が必要となっています。政府予算の増加や医療インフラの整備は、こうした検査に不可欠なコンポーネントの需要をさらに押し上げています。

自動PCRシステムや次世代シーケンシングプラットフォームなどの診断機器の技術的進歩が、腸疾患検査市場レポートにおける機器需要をさらに押し上げています。高スループット、高信頼性、高精度の診断ツールへのニーズが、先端機器の採用を後押ししています。特に新興市場における医療インフラの拡大、検査室の近代化投資の増加も需要拡大に寄与しています。疾病監視プログラムの強化や公衆衛生への取り組みも、診断機器市場をさらに刺激しています。

手法別内訳

分子診断が業界最大シェアを占める

本レポートでは、技術別の市場内訳と分析も行っています。これには分子診断学と免疫診断学が含まれます。同レポートによると、分子診断法が最大のシェアを占めています。

同市場における分子診断技術の需要は、その高精度、高感度、迅速なターンアラウンドタイムによって牽引されています。PCRや次世代シーケンシングなどのこれらの技術は、幅広い病原体の正確な同定を可能にし、疾病管理やアウトブレイクコントロールを改善します。例えば、2023年11月、ロシュはLightCycler（R）PRO Systemの発売を発表しました。このLightCycler（R）PRO Systemは、以前のLightCycler（R）Systemの実績あるゴールドスタンダード技術をベースにしています。この新システムは、トランスレーショナルリサーチと体外診断のギャップを埋めながら、性能と使いやすさの水準を引き上げます。LightCycler PROシステムはロシュの分子PCR検査ポートフォリオをさらに補完するもので、研究を行う人々から、がん、感染症、その他の公衆衛生上の課題について患者を検査する人々まで、さまざまな医療専門家向けのソリューションを含んでいます。このことが、世界中で腸疾患検査の需要をさらに押し上げています。

疾患タイプ別内訳

細菌性腸疾患が業界の最大シェアを占める

本レポートでは、疾患タイプ別に市場を詳細に区分・分析しています。これには、細菌性腸疾患（C. Difficile、カンピロバクター症、コレラ、大腸菌、ピロリ菌、サルモネラ症、赤痢）、ウイルス性腸疾患（ロタウイルス、ノロウイルス、その他）、寄生虫性腸疾患（アメーバ症、クリプトスポリジウム症、ジアルジア症）が含まれます。報告書によると、細菌性腸疾患が最大の市場シェアを占めています。

細菌性腸疾患検査の需要は、公衆衛生上の重大なリスクとなるC. difficile、大腸菌、サルモネラ症のような感染症の高い有病率が原動力となっています。迅速で正確な診断は、効果的な治療、アウトブレイク管理、感染制御に不可欠です。ピロリ菌が重篤な胃腸疾患と関連していることも、検査需要を後押ししています。食品媒介と水媒介アウトブレイクの増加、厳格な食品安全規制、効率的な医療介入の必要性は、細菌性腸疾患検査市場をさらに押し上げます。

エンドユーザー別内訳

本レポートでは、エンドユーザー別の市場内訳と分析も詳細に掲載しています。これには、病院診断ラボ、独立診断ラボ、学術研究機関、その他が含まれます。

病院診断ラボでは、腸疾患検査の需要は、効果的な患者管理と治療を保証するための迅速かつ正確な診断の必要性によって牽引されています。患者数が多く、消化器感染症の診断が重要であるため、信頼性が高く効率的な検査プロトコルが必要となります。

独立系の診断検査施設は、その専門的なサービスと迅速で大量の検査を提供する能力により、需要があります。定期的なスクリーニング、アウトブレイク管理、高度な診断技術の提供において重要な役割を果たし、医療プロバイダーと患者双方のニーズに応えています。このことが、さらに前向きな腸疾患検査市場の展望を生み出しています。

学術・研究機関では、腸内病原体の研究、革新的な診断法の開発、疫学研究が需要を牽引しています。感染症研究への資金提供や助成金の増加は、包括的で精密な検査能力の必要性を高め、科学の進歩や公衆衛生への取り組みを支援しています。

地域別内訳

アジア太平洋が市場をリードし、最大の腸疾患検査市場シェアを占める

本レポートでは、北米（米国、カナダ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、ロシア、その他）、アジア太平洋（中国、日本、インド、韓国、オーストラリア、インドネシア、その他）、ラテンアメリカ（ブラジル、メキシコ、その他）、中東アフリカを含む主要地域市場についても包括的に分析しています。報告書によると、アジア太平洋は腸疾患検査の最大市場です。

アジア太平洋の腸疾患検査市場は、衛生環境の悪化による消化管感染症の罹患率の増加が牽引しています。発展途上国に居住する小児における下痢の負担と病因に関するGlobal Enteric Multicenter Study（GEMS）の最近のデータでは、ロタウイルス、クリプトスポリジウム属、腸管毒素原性大腸菌（ETEC）、赤痢菌が下痢性疾患と死亡の主要原因であることが示されています。さらに、ノロウイルス感染症は食中毒の主要原因であり、下痢症例の約20％に関連しており、小児でも成人でも同様の有病率です。その結果、健康問題に対する意識の高まり、疾病管理に対する政府の取り組みの増加、医療インフラの改善も需要を押し上げています。診断技術の進歩や、食品や水を媒介とする疾病の有病率の上昇が、市場の成長をさらに後押ししています。急速な都市化と、医療へのアクセスが向上した中産階級の人口基盤の拡大が、市場の成長に寄与しています。

競合情勢：

市場調査レポートでは、市場の競合情勢についても包括的に分析しています。主要企業の詳細プロファイルも掲載しています。腸疾患検査業界の主要市場企業には、Abbott Laboratories、BD（Becton, Dickinson and Company）、Bio-Rad Laboratories Inc.、Biomerica Inc.、Biomerieux SA、Cepheid Inc.（Danaher Corporation）、Coris BioConcept、DiaSorin、Meridian Bioscience Inc.、Quest Diagnosticsなどがあります。

（これは主要参入企業の一部一覧であり、完全なリストは報告書に記載されていることに留意されたい）。

腸疾患検査市場の競合情勢は、Abbott Laboratories、Thermo Fisher Scientific、Bio-Rad Laboratories、Becton, Dickinson and Companyなどの主要参入企業による競争が激しいです。これらの企業は、分子診断や迅速検査キットを含む高度な診断技術の開発に注力し、検出精度とスピードを高めています。例えば、Thermo Fisher Scientificは2023年7月、Diomni Enterprise Softwareを発表しました。このソフトウェアは、エラーの起こりやすい手作業による分子検査ワークフローの課題に対処するため、ルーチン診断検査を合理化し、標準化と結果までの時間短縮を支援します。Diomni Enterpriseは、ワークフローのステップを1つのインターフェースで接続することにより、今日の急速に変化する検査環境に動的に対応するラボの能力を高めることができます。

腸疾患検査市場ニュース：

2023年3月、Biomerica, Inc.はInFoods（R）IBS検査の発売を発表しました。この検査はCLIA認定、CAP認定の高複雑性検査施設で実施され、臨床検査室開発検査（LDT）として提供されます。当社はさらに、InFoods IBS製品がLDTとして提供されるために必要なすべてのバリデーション検査が完了したことを発表しました。最初の患者サンプルは処理済みです。

2022年10月、科学セグメントの世界的リーダーであるThermo Fisher Scientific社は、一般的な消化管（GI）細菌を検出し、臨床医が感染症の根本原因を特定し、患者に最も適切な治療をより迅速に実施できるようにするために設計されたCE-IVDマークのパネルであるTaqPath腸内細菌セレクトパネルの発売を発表しました。このパネルは2022年5月にIVDDの有効性が確認され、登録されました。

本レポートで扱う主要質問

  • 世界の腸疾患検査市場はこれまでどのように推移し、今後どのように推移するのか？
  • 世界の腸疾患検査市場における促進要因、抑制要因、機会は何か？
  • 各駆動要因、抑制要因、機会が世界の腸疾患検査市場に与える影響は？
  • 主要な地域市場とは？
  • 最も魅力的な腸疾患検査市場はどの国か？
  • 製品タイプ別の市場内訳は？
  • 腸疾患検査市場で最も魅力的な製品タイプは？
  • 手法別の市場内訳は？
  • 腸疾患検査市場で最も魅力的な手法は？
  • 疾患タイプ別の市場内訳は？
  • 腸疾患検査市場で最も魅力的な疾患タイプは？
  • エンドユーザー別の市場内訳は？
  • 腸疾患検査市場で最も魅力的なエンドユーザーは？
  • 市場の競合構造は？
  • 世界の腸疾患検査市場における主要参入企業/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の腸疾患検査市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 試薬と消耗品
  • 装置

第7章 市場内訳：手法別

  • 分子診断
  • 免疫診断

第8章 市場内訳：疾患タイプ別

  • 細菌性腸疾患
    • 市場動向
    • 主要タイプ
      • C.ディフィシル
      • カンピロバクター症
      • コレラ
      • 大腸菌
      • ピロリ菌
      • サルモネラ症
      • 細菌性赤痢
    • 市場予測
  • ウイルス性腸疾患
    • 市場動向
    • 主要タイプ
      • ロタウイルス
      • ノロウイルス
      • その他
    • 市場予測
  • 寄生虫性腸疾患
    • 市場動向
    • 主要タイプ
      • アメーバ症
      • クリプトスポリジウム症
      • ジアルジア症
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 病院診断ラボ
  • 独立診断ラボ
  • 学術研究機関
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • BD（Becton, Dickinson and Company）
    • Bio-Rad Laboratories Inc.
    • Biomerica Inc.
    • Biomerieux SA
    • Cepheid Inc.（Danaher Corporation）
    • Coris BioConcept
    • DiaSorin
    • Meridian Bioscience Inc.
    • Quest Diagnostics
図表

List of Figures

  • Figure 1: Global: Enteric Disease Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Enteric Disease Testing Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Enteric Disease Testing Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Enteric Disease Testing Market: Breakup by Technique (in %), 2023
  • Figure 5: Global: Enteric Disease Testing Market: Breakup by Disease Type (in %), 2023
  • Figure 6: Global: Enteric Disease Testing Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Enteric Disease Testing Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Enteric Disease Testing Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Enteric Disease Testing (Reagents and Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Enteric Disease Testing (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Enteric Disease Testing (Equipment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Enteric Disease Testing (Equipment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Enteric Disease Testing (Molecular Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Enteric Disease Testing (Molecular Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Enteric Disease Testing (Immunodiagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Enteric Disease Testing (Immunodiagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Enteric Disease Testing (Bacterial Enteric Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Enteric Disease Testing (Bacterial Enteric Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Enteric Disease Testing (Viral Enteric Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Enteric Disease Testing (Viral Enteric Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Enteric Disease Testing (Parasitic Enteric Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Enteric Disease Testing (Parasitic Enteric Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Enteric Disease Testing (Hospital Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Enteric Disease Testing (Hospital Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Enteric Disease Testing (Independent Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Enteric Disease Testing (Independent Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Enteric Disease Testing (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Enteric Disease Testing (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Enteric Disease Testing (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Enteric Disease Testing (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: North America: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: North America: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: United States: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: United States: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Canada: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Canada: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Asia Pacific: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Asia Pacific: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: China: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: China: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Japan: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Japan: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: India: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: India: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: South Korea: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: South Korea: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Australia: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Australia: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Indonesia: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Indonesia: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Others: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Others: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Europe: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Europe: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Germany: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Germany: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: France: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: France: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: United Kingdom: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: United Kingdom: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Italy: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Italy: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Spain: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Spain: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Russia: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Russia: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Latin America: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Latin America: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Brazil: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Brazil: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Mexico: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Mexico: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Middle East and Africa: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Middle East and Africa: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Enteric Disease Testing Industry: SWOT Analysis
  • Figure 80: Global: Enteric Disease Testing Industry: Value Chain Analysis
  • Figure 81: Global: Enteric Disease Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Enteric Disease Testing Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Enteric Disease Testing Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Enteric Disease Testing Market Forecast: Breakup by Technique (in Million US$), 2024-2032
  • Table 4: Global: Enteric Disease Testing Market Forecast: Breakup by Disease Type (in Million US$), 2024-2032
  • Table 5: Global: Enteric Disease Testing Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Enteric Disease Testing Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Enteric Disease Testing Market Structure
  • Table 8: Global: Enteric Disease Testing Market: Key Players
目次
Product Code: SR112024A2544

The global enteric disease testing market size reached US$ 4.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.1% during 2024-2032. The rising incidences of gastrointestinal infections, increasing awareness about the early detection, advancements in diagnostic technologies, the growing demand for rapid and accurate testing methods, and rising global focus on food and water safety standards are some of the factors propelling the growth of the market.

Enteric Disease Testing Market Analysis:

Major Market Drivers: The rising prevalence of gastrointestinal infections across the globe represents the major driver of the market. Factors including poor sanitation, contaminated water, and foodborne pathogens contribute to the increasing incidence of enteric diseases. Significant advancements in diagnostic technologies offering rapid and accurate results further driving the market growth.

Key Market Trends: The widespread adoption of molecular diagnostics represents the key trends in the market. Techniques including polymerase chain reaction (PCR) and next-generation sequencing (NGS) are gaining popularity due to their high sensitivity, specificity, and rapid turnaround time. These advanced diagnostic methods enable the detection of a wide range of pathogens, contributing to more accurate and comprehensive testing.

Geographical Trends: Asia Pacific accounts for the largest region in the enteric disease testing market growth. The high incidence of gastrointestinal infections is driving the market growth across the region due to poor sanitation, increasing healthcare awareness, government initiatives for disease control, and advancements in diagnostic technologies.

Competitive Landscape: Some of the major market players in the enteric disease testing industry include Abbott Laboratories, BD (Becton, Dickinson and Company), Bio-Rad Laboratories Inc., Biomerica Inc., Biomerieux SA, Cepheid Inc. (Danaher Corporation), Coris BioConcept, DiaSorin, Meridian Bioscience Inc. and Quest Diagnostics, among many others.

Challenges and Opportunities: The market faces various challenges including limited access to advanced diagnostic facilities in remote and low-income regions, which hampers timely disease detection. However, the market also faces several opportunities such as advancements in molecular diagnostics and point-of-care testing which offer rapid and accurate results.

Enteric Disease Testing Market Trends:

Rising Incidence of Gastrointestinal Infections

The growing prevalence of enteric diseases due to poor sanitation, contaminated food and water, and high population density, especially in developing regions, is driving the demand for effective diagnostic testing. According to an article published by the Times of India in 2024, Bengaluru witnesses a rise in gastrointestinal infections attributed to contaminated water sources and poor sanitation. Children are at risk of dehydration due to diarrhea, emphasizing the importance of ORS and avoiding milk during infections. According to the WHO, approximately 1.5 million people worldwide die of diarrheal disease alone. Children under the age of 5 living in developing countries are particularly affected by conditions such as diarrhea and vomiting through malnutrition and death. This is further boosting the enteric disease testing market value significantly.

Growing Government Initiatives and Regulations

The rising government and health organizations are implementing strict food and water safety standards and investing in public health infrastructure. This further increases the need for regular and reliable enteric disease testing to prevent outbreaks and ensure public safety which is further contributing to the growth of the market. For instance, in April 2024, The Food Safety and Standards Authority of India (FSSAI) launched an extensive awareness and sensitization program targeting major markets in the national capital, in collaboration with the Food Safety Department, Delhi. Similarly, the National Health Mission (NHM), a key program under the Modi government, focuses on improving healthcare infrastructure, providing essential drugs and diagnostics, and strengthening human resource capabilities at the grassroots level. These initiatives are aimed at reducing the need for patients to seek expensive treatments outside their localities which is further boosting the enteric disease testing market forecast over the coming years.

Significant Advancements in Diagnostic Technologies

The increasing innovation in molecular diagnostics including polymerase chain reaction (PCR) and next-generation sequencing (NGS), provide rapid, accurate, and comprehensive detection of enteric pathogens, which is boosting the market growth. For instance, in August 2023, ArcticZymes Technologies (AZT) announced the launch of its new product, AZtaq(TM) DNA Polymerase. AZtaq(TM) is a high-quality thermostable DNA polymerase suitable for use in polymerase chain reaction (PCR) applications. Launched the AZtaq(TM) is a natural expansion of the Company's molecular tools portfolio. Being an essential enzyme in PCR, the thermostable DNA polymerase plays a pivotal role and enables numerous applications within molecular diagnostics and research. This is further driving the enteric disease testing market revenue across the globe.

Enteric Disease Testing Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, technique, disease type, and end user.

Breakup by Product Type:

Reagents and Consumables

Equipment

The report has provided a detailed breakup and analysis of the market based on the product type. This includes reagents and consumables, and equipment.

The demand for reagents and consumables in the market is driven by the need for accurate and efficient diagnostic processes. Frequent testing for gastrointestinal pathogens requires a constant supply of high-quality reagents and consumables. Additionally, the rise in infectious disease prevalence, coupled with advancements in molecular and rapid testing methods, necessitates the use of specialized consumables. Increased government funding and healthcare infrastructure development further boost demand for these essential testing components.

Technological advancements in diagnostic machinery, such as automated PCR systems and next-generation sequencing platforms are further driving the demand for equipment in the enteric disease testing market report. The need for high-throughput, reliable, and precise diagnostic tools drive the adoption of advanced equipment. Expanding healthcare infrastructure, particularly in emerging markets, and increased investment in laboratory modernization also contribute to the growing demand. Enhanced disease surveillance programs and public health initiatives further stimulate the market for diagnostic equipment.

Breakup by Technique:

Molecular Diagnostics

Immunodiagnostics

Molecular diagnostics holds the largest share of the industry

A detailed breakup and analysis of the market based on the technique have also been provided in the report. This includes molecular diagnostics and immunodiagnostics. According to the report, molecular diagnostics accounted for the largest enteric disease testing market share.

The demand for molecular diagnostics techniques in the market is driven by their high accuracy, sensitivity, and rapid turnaround times. These techniques, such as PCR and next-generation sequencing, enable precise identification of a wide range of pathogens, improving disease management and outbreak control. For instance, in November 2023, Roche announced the launch of the LightCycler(R) PRO System based on the proven gold standard technology of the LightCycler(R) Systems that came before it. This new system raises the bar for performance and usability while bridging the gap between translational research and in vitro diagnostics. The LightCycler PRO System further complements Roche's molecular PCR testing portfolio, which includes solutions for a variety of healthcare professionals - from those performing research to those testing patients for cancer, infectious diseases, and other public health challenges. This is further driving the enteric disease testing demand across the globe.

Breakup by Disease Type:

Bacterial Enteric Disease

C. Difficile

Campylobacteriosis

Cholera

E. Coli

H. Pylori

Salmonellosis

Shigellosis

Viral Enteric Disease

Rotavirus

Norovirus

Others

Parasitic Enteric Disease

Amebiasis

Cryptosporidiosis

Giardiasis

Bacterial enteric disease holds the largest share of the industry

The report has provided a detailed breakup and analysis of the market based on the disease type. This includes Bacterial Enteric Disease (C. Difficile, Campylobacteriosis, Cholera, E. Coli, H. Pylori, Salmonellosis, and Shigellosis), Viral Enteric Disease (Rotavirus, Norovirus, and Others), and Parasitic Enteric Disease (Amebiasis, Cryptosporidiosis, and Giardiasis). According to the report, Bacterial Enteric Disease accounted for the largest market share.

The demand for enteric disease testing in bacterial types is driven by the high prevalence of infections like C. difficile, E. coli, and Salmonellosis, which pose significant public health risks. Rapid, accurate diagnostics are crucial for effective treatment, outbreak management, and infection control. The association of H. pylori with severe gastrointestinal conditions also fuels testing demand. Increasing foodborne and waterborne outbreaks, stringent food safety regulations, and the need for efficient healthcare interventions further boost the market for bacterial enteric disease testing.

Breakup by End User:

Hospital Diagnostic Laboratories

Independent Diagnostic Laboratories

Academic and Research Institutes

Others

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospital diagnostic laboratories, independent diagnostic laboratories, academic and research institutes, and others.

In hospital diagnostic laboratories, the demand for enteric disease testing is driven by the necessity for prompt and accurate diagnosis to ensure effective patient management and treatment. High patient volumes and the critical nature of diagnosing gastrointestinal infections necessitate reliable and efficient testing protocols.

Independent diagnostic laboratories see demand due to their specialized services and ability to provide rapid, high-volume testing. They play a crucial role in routine screening, outbreak management, and offering advanced diagnostic techniques, meeting the needs of both healthcare providers and patients. This is further creating a positive enteric disease testing market outlook.

In academic and research institutes, demand is driven by the focus on studying enteric pathogens, developing innovative diagnostic methods, and conducting epidemiological research. Increased funding and grants for infectious disease research enhance the need for comprehensive and precise testing capabilities, supporting scientific advancements and public health initiatives.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Asia Pacific leads the market, accounting for the largest enteric disease testing market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific represents the largest market for enteric disease testing.

The market for enteric disease testing in Asia Pacific is driven by the increasing incidence rates of gastrointestinal infections due to poor sanitation and hygiene. Recent data from the Global Enteric Multicenter Study (GEMS) on the burden and etiology of diarrhea among children residing in developing countries showed that rotavirus, Cryptosporidium spp., enterotoxigenic Escherichia coli (ETEC), and Shigella spp. are the major causes of diarrheal diseases and death. Furthermore, norovirus infections are the principal cause of foodborne disease outbreaks and are associated with approximately 20% of diarrhea cases, with similar prevalence in both children and adults. Consequently, the growing awareness of health issues, increased government initiatives for disease control, and improvements in healthcare infrastructure also boost demand. Advancements in diagnostic technologies and the rising prevalence of food and waterborne diseases further propel the market growth. Rapid urbanization and the expanding middle class population base, with greater access to healthcare, are contributing to the market growth.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the enteric disease testing industry include Abbott Laboratories, BD (Becton, Dickinson and Company), Bio-Rad Laboratories Inc., Biomerica Inc., Biomerieux SA, Cepheid Inc. (Danaher Corporation), Coris BioConcept, DiaSorin, Meridian Bioscience Inc. and Quest Diagnostics.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

The competitive landscape of the enteric disease testing market is highly competitive with key players such as Abbott Laboratories, Thermo Fisher Scientific, Bio-Rad Laboratories, and Becton, Dickinson and Company. These players focus on developing advanced diagnostic technologies, including molecular diagnostics and rapid testing kits, to enhance detection accuracy and speed. For instance, in July 2023, Thermo Fisher Scientific introduced Diomni Enterprise Software, helping streamline routine diagnostics testing for standardization and faster time-to-results to address challenges with error-prone, manual molecular testing workflows. By connecting workflow steps within one interface, Diomni Enterprise can increase a lab's ability to dynamically respond to today's rapidly changing testing environment.

Enteric Disease Testing Market News:

In March 2023, Biomerica, Inc. announced the launch of its InFoods(R) IBS test. The test is being performed in a CLIA-certified, and CAP-accredited high-complexity laboratory facility and offered as a laboratory-developed test (LDT). The Company further announced all validation testing necessary for the InFoods IBS product to be offered as an LDT has been completed. The first patient samples have been processed.

In October 2022, Thermo Fisher Scientific, the world leader in the field of science, announced the launch of the TaqPath Enteric Bacterial Select Panel, a CE-IVD marked panel designed to detect common gastrointestinal (GI) bacteria and help enable clinicians to identify the root cause of an infection and administer the most appropriate treatment to their patients more quickly. The panel was validated and registered under IVDD in May 2022.

Key Questions Answered in This Report:

  • How has the global enteric disease testing market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global enteric disease testing market?
  • What is the impact of each driver, restraint, and opportunity on the global enteric disease testing market?
  • What are the key regional markets?
  • Which countries represent the most attractive enteric disease testing market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the enteric disease testing market?
  • What is the breakup of the market based on the technique?
  • Which is the most attractive technique in the enteric disease testing market?
  • What is the breakup of the market based on the disease type?
  • Which is the most attractive disease type in the enteric disease testing market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the enteric disease testing market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global enteric disease testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Enteric Disease Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Reagents and Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Equipment
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technique

  • 7.1 Molecular Diagnostics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Immunodiagnostics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Disease Type

  • 8.1 Bacterial Enteric Disease
    • 8.1.1 Market Trends
    • 8.1.2 Major Types
      • 8.1.2.1 C. Difficile
      • 8.1.2.2 Campylobacteriosis
      • 8.1.2.3 Cholera
      • 8.1.2.4 E. Coli
      • 8.1.2.5 H. Pylori
      • 8.1.2.6 Salmonellosis
      • 8.1.2.7 Shigellosis
    • 8.1.3 Market Forecast
  • 8.2 Viral Enteric Disease
    • 8.2.1 Market Trends
    • 8.2.2 Major Types
      • 8.2.2.1 Rotavirus
      • 8.2.2.2 Norovirus
      • 8.2.2.3 Others
    • 8.2.3 Market Forecast
  • 8.3 Parasitic Enteric Disease
    • 8.3.1 Market Trends
    • 8.3.2 Major Types
      • 8.3.2.1 Amebiasis
      • 8.3.2.2 Cryptosporidiosis
      • 8.3.2.3 Giardiasis
    • 8.3.3 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospital Diagnostic Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Independent Diagnostic Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic and Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 BD (Becton, Dickinson and Company)
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bio-Rad Laboratories Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Biomerica Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Biomerieux SA
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Cepheid Inc. (Danaher Corporation)
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Coris BioConcept
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 DiaSorin
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Meridian Bioscience Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Quest Diagnostics
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis